News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Stampacchia Otello
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/06/2021 |
3
| Omega Fund VI, L.P. (10% Owner) has filed a Form 3 on Theseus Pharmaceuticals, Inc. |
| 03/25/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/12/2021 |
3
| Omega Fund V, L.P. (10% Owner) has filed a Form 3 on Nuvation Bio Inc. |
| 01/06/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/08/2020 |
3
| Omega Fund V, L.P. (10% Owner) has filed a Form 3 on Kronos Bio, Inc. |
| 10/08/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/26/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/26/2019 |
3
| Omega Fund V, L.P. (10% Owner) has filed a Form 3 on Morphic Holding, Inc. |
| 04/22/2019 |
3
| Global Life Bioventure V Sarl (10% Owner) has filed a Form 3 on IMMUNIC, INC. |
| 02/07/2019 |
3
| Omega Fund V, L.P. (10% Owner) has filed a Form 3 on Gossamer Bio, Inc. |
| 07/19/2018 |
3
| Omega Fund IV, L.P. (10% Owner) has filed a Form 3 on Replimune Group, Inc. |
| 06/27/2018 |
3
| Omega Fund IV, L.P. (10% Owner) has filed a Form 3 on Translate Bio, Inc. |
| 06/20/2018 |
3
| Omega Fund IV, L.P. (10% Owner) has filed a Form 3 on Kezar Life Sciences, Inc. |
|
|